Ferric Carboxymaltose Injection – Retafer FCM Injection

Ferric Carboxymaltose Injection – Fast-Track Recovery from Iron Deficiency Anaemia.

Retafer FCM Injection: The composition of Ferric Carboxymaltose, eq. to elemental iron 50mg, is helpful for patients intolerant to or unresponsive to oral iron, and Ferric Carboxymaltose is a next-generation intravenous iron therapy for rapid and effective correction of iron deficiency anaemia. It delivers elemental iron directly to the bloodstream, bypassing GI absorption, and provides prolonged iron availability for erythropoiesis.

Recommended By Specialists:
General Practitioners: It is mainly used to differ to treat the disease for the treatment general cases of iron-deficiency anaemia.
Gynaecologists: It is mainly used to differ to treat the disease associated for the treatment for anaemia during pregnancy, postpartum, or menstrual-related anaemia.
Haematologists: It is mainly used to differentiate the disease associated with moderate to severe anaemia

KEY BENEFITS:
Excellent Tolerability Profile – Non-dextran formulation with reduced risk of hypersensitivity and infusion reactions.
Superior Bioavailability – Rapid uptake by bone marrow and sustained increase in haemoglobin and ferritin levels.
Single-Dose Convenience – Enables high-dose iron delivery (up to 1000 mg) in one or two sittings, ensuring faster haemoglobin correction.

INDICATIONS:
Iron Deficiency Anaemia
Anaemia in CKD
Perioperative Anemia
Postpartum Iron Deficiency
Anaemia in Oncology & Cardiology Patients